Rolinsatamab
Product Specifications
CAS Number
2095467-30-2
Target
ADC Antibody, IL Receptor
Related Pathways
Immunology/Inflammation, Antibody-drug Conjugate/ADC Related
Purity
>95%
Bioactivity
Rolinsatamab is a fully humanized selective monoclonal antibody that is a potent dual inhibitor of IL-4 and IL-13. Rolinsatamab chimeric antigen receptor sequence T cells. Rolinsatamab can be used to prevent and treat immune diseases.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM1888-50 1x 50 µL
CD1a / HTA1 (Mature Langerhans Cells Marker) (rC1A/711), 1mg/mL
Sign In for Pricing
View Details 
BNC881731-100 1x 100 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (CHGA/1731R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC043168-100 1x 100 µL
GRP94 / HSP90B1 (Glucose-Regulated Protein 94) (Endoplasmic Reticulum Marker) (HSP90B1/3168R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-C365135-1G 1 g
7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic Acid
Sign In for Pricing
View Details 
